Quality of life in patients with COPD, depending on the presence of comorbidities

Introduction. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the world among chronic diseases. The article discusses the relationship between the quality of life of patients with COPD and the presence of diseases associated mainly with hypertension, diabetes and hyperlipidemia. The examination includes subjective and holistic assessment of the patient’s health condition, which allows to notice any disorders and deficits in the functioning of patients with this disease.

Aim. The aim of the study was to determine the quality of life of patients with chronic obstructive pulmonary disease depending on the comorbidities.

Material and methods. The study included 319 COPD patients treated in the Lung Diseases Clinic with chronic obstructive pulmonary disease. The study was conducted using a diagnostic survey method and analyzing medical records. The research tool assessing patients quality of life was the SGRQ questionnaire (Saint George Hospital Questionaire).

Results. Respondents who had a myocardial infarction had a slightly lower quality of life in the „Impact on life subscale” (p=0.047). It was noted that patients with hypertension had a lower quality of life in the domain of “Activity” (p<0.05) and “Impact on life”(p<0.001). However, with hyperlipidemia, a lower quality of life was noticeable in the “Symptoms” (p<0.001) and “Impact on life” subscale (p=0.002).

Conclusions. Exacerbation of symptoms in the course of chronic obstructive pulmonary disease, a history of myocardial infarction, hypertension and hyperlipidemia are signifi cantly related to the decreased quality of life of patients. Prevention of these civilization diseases can prevent deterioration of the quality of life of patients.

Quality of life in patients with COPD, depending on the presence of comorbidities.pdf

References

1. Ulenberg A, Ulenberg G, Felsmann M, i wsp. Edukacja jako istotny aspekt w opiece nad pacjentem z Przewlekłą Obturacyjną Chorobą Płuc (POChP). Journal of Education, Health and Sport. 2017; 7.

2. Kupryś-Lipińska I, Kuna P. Impact of chronic obstructive pulmonary disease (COPD) on patient’s life and his family. Advances in Respiratory Medicine. 2014: 82; 82-95

3. Janice M, PeiYee T, Mac Aogáin M, et al. The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD. Respirology. 2017; 22: 634- 650.

4. Górska K, JankowskiP, Krenke R. POChP w codziennej praktyce klinicznej. Biblioteka Lekarza Praktyka. 2018; 22-24, 40-51.

5. Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD.Respiratory Research. 2017; 18: 67

6. Kessler R, Partridge MR, Miravitlles M, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. EurRespir J. 2011; 37: 264–272.

7. Dury R. COPD and emotional distress: not always noticed and therefore untreated. Br J Community Nurs. 2016;21:138-141

8. Walentynowicz-Moryl K. Społeczny wymiar zdrowia. Relacje. Studia z nauk społecznych. 2016;1: 71-81

9. Janice M, PeiYee T, Mac Aogáin M. et al.The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD. Respirology. 2017; 22: 634- 650.

10. Grochans E, Bąk A, Reczyńska A, i wsp. Czynniki społeczno-demograficzne wpływajace na jakość życia pacjentów z astma i POChP. Family Medicine & Primary Care Review. 2013; 15(4): 536-539.

11. Kuzniar T, Patkowski J, Libhart J, i wsp. Ocena polskiej wersji St. George’s Respiratory Questionnarie u chorych na astmę oskrzelową. Pneumonol. Alergol. Pol. 1999;67: 497-503

12. Streng KW, Nauta JF, Hillege HL. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. International Journal of Cardiology. 2018; 71:132-139.

13. Hyun L, Sun Hye S, Seonhye G, et al. Racial differences in comorbidity profile among patients with chronic obstructive pulmonary disease. BMC Medicine. 2018; 16: 178.

14. Rosińczuk J, Przyszlak M, Uchmanowicz I. Sociodemographic and clinical factors affecting the quality of life of patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease. 2018; 13: 2869- 2882.

15. Rasputina L, Didenko D, Ovcharuk M. Life quality parameters in patients with combination of stable ischemic heart disease and chronic obstructive pulmonary disease. Wiadomości Lekarskie. 2018;71(8):1560-1565.

16. Kuzniar T, Patkowski J, Libhart J, i wsp. Ocena polskiej wersji St. George’s Respiratory Questionnarie u chorych na astmę oskrzelową. Pneumonol. Alergol. Pol. 1999; 67: 497-503.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.